Huntsman Corporation (NYSE: HUN) just reported its fourth quarter 2025 results, and let’s just say the numbers are less than inspiring. The company posted a net loss of $96 million—an improvement over the previous year's $141 million loss—but that’s about where the good news ends. Diluted loss per share improved to $0.56 from $0.82 in Q4 2024, yet an adjusted net loss of $63 million highlights ongoing issues.
The revenue picture isn't pretty either; Huntsman's total revenues hit $1.355 billion for Q4 2025 compared to $1.452 billion last year—a decline of nearly 7%. This trend isn’t just a blip on the radar; full-year revenues also dipped from approximately $6 billion to around $5.683 billion in 2025, showing sustained weakness across their operations.
Cash Flow Conundrum: What Gives?
If you dig into the details, things get murkier. The free cash flow dropped significantly to just $20 million this quarter versus a robust $108 million last year—this isn't exactly what you'd call healthy liquidity management. Operating cash flow fell sharply as well—from about $298 million to only $77 million this quarter! You have to wonder if management is facing an uphill battle with cash generation amidst these declining earnings.
"We remain confident that the economic cycle for chemicals will eventually improve in our core markets... meaningful changes may not occur in the immediate term."
This quote from CEO Peter R. Huntsman is meant to instill some confidence but frankly raises more questions than it answers regarding their strategy going forward and how they plan to navigate these tumultuous waters.
Segment Analysis: Weakness Across the Board
Diving into segment performance, there’s not much solace here either:
- Polyurethanes: Revenues dropped by 8%, mainly due to lower average selling prices amid shifting supply-demand dynamics.
- Performance Products: Revenues saw a decrease of 6%, primarily attributed to competitive pressures forcing prices down.
- Advanced Materials: Revenue fell by 4%, largely because of lower sales volumes despite some positive impacts from foreign currency movements against the dollar.
The combined segments' adjusted EBITDA plummeted too—from $71 million last year down to only $35 million this quarter! This paints a stark picture of financial health across their operational segments—and trust me when I say traders should be paying attention here.
